Publications by authors named "Rebecca Aft"

Claim this Profile
N
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.
William J Gradishar, Meena S Moran, Jame Abraham, Vandana Abramson, Rebecca Aft

J Natl Compr Canc Netw· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Trends in Incidence and Management of Pregnancy-Associated Breast Cancer in a National Sample Using Claims Data.
Kaamya Varagur, Joseph G Ribaudo, Matthew Keller, Nicholas R Fadell, Cameron Martin, Rebecca Aft

J Surg Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors.
Jennifer Ma, Rachna Shah, Andrew C Bell, Niamh McDermott, Xin Pei, Rebecca F Aft

Int J Radiat Oncol Biol Phys· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study.
Patrick Neven, Nicole Stahl, Maria Vidal, Miguel Martín, Peter A Kaufman, Philippe Aftimos, Rebecca Aft

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.
Michael D Iglesia, Reyka G Jayasinghe, Siqi Chen, Nadezhda V Terekhanova, John M Herndon, Rebecca Aft

Nat Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
William J Gradishar, Meena S Moran, Jame Abraham, Vandana Abramson, Rebecca Aft

J Natl Compr Canc Netw· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models.
Zhanfang Guo, Jingqin Luo, R Jay Mashl, Jeremy Hoog, Piyush Maiti, Rebecca Aft

Cancer Res Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME.
Tri Giang Phan, Katherine N Weilbaecher, Rebecca Aft, Peter I Croucher, Christine L Chaffer

Cancer Discov· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.
Michael D Iglesia, Reyka G Jayasinghe, Siqi Chen, Nadezhda V Terekhanova, John M Herndon, Rebecca Aft

bioRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.
Syeda Maheen Batool, Anudeep Yekula, Prerna Khanna, Tiffaney Hsia, Austin S Gamblin, Rebecca Aft

Cell Rep Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.
C Alston James, John M Baer, Chong Zou, Usman Y Panni, Brett L Knolhoff, Rebecca Aft

Cancer Immunol Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
William J Gradishar, Meena S Moran, Jame Abraham, Vandana Abramson, Rebecca Aft

J Natl Compr Canc Netw· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).
Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, Ellis Levine, Jingqin Luo, Rebecca Aft

NPJ Breast Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
William J Gradishar, Meena S Moran, Jame Abraham, Rebecca Aft, Doreen Agnese

J Natl Compr Canc Netw· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of consensus guidelines for breast-conserving surgery in patients with ductal carcinoma in situ.
Abigail Tremelling, Rebecca L Aft, Amy E Cyr, William E Gillanders, Katherine Glover-Collins

Cancer Rep (Hoboken)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.
Hua Sun, Song Cao, R Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Rebecca Aft

Nat Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.
Sreeraj G Pillai, Chidananda M Siddappa, Cynthia Ma, Jackie Snider, Madhurima Kaushal, Rebecca Aft

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.
Andreas D Hartkopf, Sara Y Brucker, Florin-Andrei Taran, Nadia Harbeck, Alexandra von Au, Rebecca Aft

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
Hua Sun, Song Cao, R Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Rebecca Aft

Nat Commun· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of (neo)adjuvant zoledronic acid therapy in locally advanced breast cancer.
Andrew P Jallouk, Sriram Paravastu, Katherine Weilbaecher, Rebecca L Aft

Breast Cancer Res Treat· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
William J Gradishar, Meena S Moran, Jame Abraham, Rebecca Aft, Doreen Agnese

J Natl Compr Canc Netw· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of postoperative opioid stewardship using a novel electronic-based automated text and phone messaging platform.
Bradley S Kushner, Wen Hui Tan, Margaret Sehnert, Katherine Jordan, Rebecca Aft

Surgery· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata.
Marie-Anne Durand, Renata W Yen, A James O'Malley, Danielle Schubbe, Mary C Politi, Rebecca Aft

Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models.
Zhanfang Guo, Tina Primeau, Jingqin Luo, Cynthia Zhang, Hua Sun, Rebecca Aft

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis